JP2006298893A5 - - Google Patents

Download PDF

Info

Publication number
JP2006298893A5
JP2006298893A5 JP2005229066A JP2005229066A JP2006298893A5 JP 2006298893 A5 JP2006298893 A5 JP 2006298893A5 JP 2005229066 A JP2005229066 A JP 2005229066A JP 2005229066 A JP2005229066 A JP 2005229066A JP 2006298893 A5 JP2006298893 A5 JP 2006298893A5
Authority
JP
Japan
Prior art keywords
group
general formula
lower alkyl
substituent
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005229066A
Other languages
English (en)
Japanese (ja)
Other versions
JP4154613B2 (ja
JP2006298893A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005229066A priority Critical patent/JP4154613B2/ja
Priority claimed from JP2005229066A external-priority patent/JP4154613B2/ja
Publication of JP2006298893A publication Critical patent/JP2006298893A/ja
Publication of JP2006298893A5 publication Critical patent/JP2006298893A5/ja
Application granted granted Critical
Publication of JP4154613B2 publication Critical patent/JP4154613B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005229066A 2004-08-06 2005-08-08 芳香族化合物 Expired - Fee Related JP4154613B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005229066A JP4154613B2 (ja) 2004-08-06 2005-08-08 芳香族化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004230092 2004-08-06
JP2005090149 2005-03-25
JP2005229066A JP4154613B2 (ja) 2004-08-06 2005-08-08 芳香族化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007300664A Division JP4931775B2 (ja) 2004-08-06 2007-11-20 芳香族化合物

Publications (3)

Publication Number Publication Date
JP2006298893A JP2006298893A (ja) 2006-11-02
JP2006298893A5 true JP2006298893A5 (https=) 2008-01-10
JP4154613B2 JP4154613B2 (ja) 2008-09-24

Family

ID=35508545

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005229066A Expired - Fee Related JP4154613B2 (ja) 2004-08-06 2005-08-08 芳香族化合物
JP2007300664A Expired - Fee Related JP4931775B2 (ja) 2004-08-06 2007-11-20 芳香族化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007300664A Expired - Fee Related JP4931775B2 (ja) 2004-08-06 2007-11-20 芳香族化合物

Country Status (16)

Country Link
US (2) US8188277B2 (https=)
EP (1) EP1773797A2 (https=)
JP (2) JP4154613B2 (https=)
KR (1) KR100927563B1 (https=)
CN (1) CN1993339B (https=)
AR (1) AR050448A1 (https=)
AU (1) AU2005268030B2 (https=)
BR (1) BRPI0514150A (https=)
CA (1) CA2573223C (https=)
IL (1) IL180884A (https=)
MX (1) MX2007001215A (https=)
MY (1) MY148905A (https=)
RU (1) RU2416608C2 (https=)
TW (1) TWI353983B (https=)
WO (1) WO2006014012A2 (https=)
ZA (1) ZA200700811B (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200700811B (en) 2004-08-06 2008-10-29 Otsuka Pharma Co Ltd Aromatic compound
AU2006204724A1 (en) 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
CA2610903A1 (en) 2005-06-16 2006-12-21 Pfizer Inc. N-(pyridin-2-yl)-sulfonamide derivatives
EP1940786B1 (en) 2005-09-16 2010-08-18 Arrow Therapeutics Limited Biphenyl derivatives and their use in treating hepatitis c
EP1945632B1 (en) 2005-11-08 2013-09-18 Vertex Pharmaceuticals Incorporated Heterocyclic modulators of atp-binding cassette transporters
CN101321529B (zh) 2005-12-05 2012-09-05 大塚制药株式会社 作为抗肿瘤剂的二芳基醚衍生物
JP5142513B2 (ja) * 2005-12-05 2013-02-13 大塚製薬株式会社 医薬
WO2007067444A1 (en) 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Bicyclic compounds with kinase inhibitory activity
US7671221B2 (en) 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
NZ571803A (en) 2006-04-07 2011-12-22 Vertex Pharma Amide indole derivatives as modulators of ATP-binding cassette transporters
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
CA2659512C (en) * 2006-06-06 2015-09-08 Critical Therapeutics, Inc. Novel piperazines, pharmaceutical compositions and methods of use thereof
US7943622B2 (en) 2006-06-06 2011-05-17 Cornerstone Therapeutics, Inc. Piperazines, pharmaceutical compositions and methods of use thereof
MX352516B (es) 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
AU2007286829B2 (en) * 2006-08-21 2013-05-02 Array Biopharma, Inc. 4-substituted phenoxyphenylacetic acid derivatives
BRPI0717106A2 (pt) * 2006-09-21 2013-10-08 Piramal Life Sciences Ltd Compostos para o tratamento de distúrbios metabólicos
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
AU2012202382B2 (en) * 2006-10-02 2014-06-26 Otsuka Pharmaceutical Co., Ltd. STAT3/5 activation inhibitor
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US7754739B2 (en) 2007-05-09 2010-07-13 Vertex Pharmaceuticals Incorporated Modulators of CFTR
TW200900072A (en) * 2007-03-22 2009-01-01 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors
US8969386B2 (en) 2007-05-09 2015-03-03 Vertex Pharmaceuticals Incorporated Modulators of CFTR
CA2695434A1 (en) * 2007-08-17 2009-02-26 Astrazeneca Ab Chemical compounds 979
EP2639224B1 (en) 2007-12-07 2016-08-24 Vertex Pharmaceuticals Incorporated Process for producing cycloalkylcarboxiamido-pyridine benzoic acids
SI2225230T1 (sl) 2007-12-07 2017-03-31 Vertex Pharmaceuticals Incorporated Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
NZ720282A (en) 2008-02-28 2017-12-22 Vertex Pharma Heteroaryl derivatives as cftr modulators
FR2932483A1 (fr) * 2008-06-13 2009-12-18 Cytomics Systems Composes utiles pour le traitement des cancers.
US8927549B2 (en) 2008-11-21 2015-01-06 High Point Pharmaceuticals, Llc Adamantyl benzamide derivatives
PE20120008A1 (es) 2009-01-12 2012-01-24 Icagen Inc Derivados de fenoxi bencenosulfonamida
JP5688918B2 (ja) * 2009-04-28 2015-03-25 大塚製薬株式会社 医薬組成物
WO2011046954A1 (en) 2009-10-13 2011-04-21 Ligand Pharmaceuticals Inc. Hematopoietic growth factor mimetic small molecule compounds and their uses
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
HRP20141190T1 (hr) * 2010-01-29 2015-01-30 Otsuka Pharmaceutical Co., Ltd. Disupstituirani derivati piridina kao antikancerogena sredstva
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
HRP20211752T1 (hr) 2010-04-07 2022-02-18 Vertex Pharmaceuticals Incorporated Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
ES2608474T3 (es) 2010-04-22 2017-04-11 Vertex Pharmaceuticals Incorporated Proceso de producción de compuestos indol cycloalkylcarboxamido
JP5872552B2 (ja) 2010-07-09 2016-03-01 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 化学化合物
WO2012015715A1 (en) 2010-07-27 2012-02-02 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
PH12013500605B1 (en) 2010-10-04 2018-07-04 Otsuka Pharma Co Ltd 4-(methylaminophenoxy)pyrdin-3-yl-benzamide derivatives for treating cancer
WO2013112804A1 (en) 2012-01-25 2013-08-01 Vertex Pharmaceuticals Incorporated Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
WO2014014841A1 (en) 2012-07-16 2014-01-23 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
EP2922596B1 (en) * 2012-08-31 2018-05-23 Novadrug, LLC Heterocyclyl carboxamides for treating viral diseases
PL2922845T3 (pl) * 2012-11-20 2018-11-30 Merial, Inc. Związki przeciwrobacze oraz ich kompozycje i sposób stosowania
JP6963896B2 (ja) 2013-11-12 2021-11-10 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Ｃｆｔｒ媒介性疾患の処置のための医薬組成物を調製する方法
ES2885181T3 (es) 2014-04-15 2021-12-13 Vertex Pharma Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
CA2949511A1 (en) * 2014-05-19 2015-11-26 Merial, Inc. Anthelmintic compounds
PT3221692T (pt) 2014-11-18 2021-09-10 Vertex Pharma Processo de realização de testagem de alta produtividade por cromatografia líquida de alta eficiência
US10316021B2 (en) 2016-11-28 2019-06-11 Pfizer Inc. Heteroarylphenoxy benzamide kappa opioid ligands
JP7185631B2 (ja) 2017-02-03 2022-12-07 サータ セラピューティクス プロプライエタリー リミテッド 抗線維化化合物
JP7444458B2 (ja) * 2018-09-21 2024-03-06 学校法人福岡大学 プリオン病治療薬
CN111847474B (zh) * 2020-07-17 2021-09-28 浙江恒澜科技有限公司 一种Ti-ITQ-24沸石分子筛及其原位合成方法和应用
TW202400588A (zh) * 2022-02-28 2024-01-01 香港商維泰瑞隆（香港）生物科技有限公司 Ｒｉｐ１調製劑、其製備及用途
CN118206542B (zh) * 2023-03-22 2025-06-27 沈阳药科大学 一种化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用
CN117843521A (zh) * 2024-01-02 2024-04-09 中国药科大学 一种作为甲状腺激素β受体激动剂的化合物及其制备方法、应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629102A (https=) * 1961-03-29
NL7111711A (https=) 1970-09-17 1972-03-21
US3715375A (en) 1970-09-17 1973-02-06 Merck & Co Inc New diphenyl sulfones
GB1494117A (en) 1974-11-02 1977-12-07 Bayer Ag Process for the preparation of acid amides
DE2707660C2 (de) 1977-02-23 1985-12-19 Bayer Ag, 5090 Leverkusen Abspalter- und Diolrest enthaltende Diisocyanat-Addukte, ihre Herstellung und Verwendung
DE2707659A1 (de) 1977-02-23 1978-08-24 Bayer Ag Selbstvernetzbare polyurethane
DE2812252A1 (de) 1978-03-21 1979-10-04 Bayer Ag 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
EP0500495A3 (en) 1991-02-21 1993-04-07 Ciba-Geigy Ag Thermosetting composition
DE69314718T2 (de) 1992-07-21 1998-02-26 Ciba Geigy Ag Oxamidsäure-Derivate als hypocholesterämische Mittel
JP3894949B2 (ja) 1993-06-30 2007-03-22 ザ、ウェルカム、ファンデーション、リミテッド 抗アテローム性動脈硬化症ジアリール化合物
NZ311995A (en) 1995-06-07 1999-03-29 Inst Materia Medica Chalcone retinoids and methods of use of same in cancer and precancer cells
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
US6489327B1 (en) 1998-02-06 2002-12-03 Max-Planck-Gesellschaft Zur Fordrungder Wisenschaften, E.V. Tryptase inhibitors
EP1060171A2 (de) 1998-02-06 2000-12-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tryptase-inhibitoren
AR015733A1 (es) * 1998-03-25 2001-05-16 Otsuka Pharma Co Ltd DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
ES2230864T3 (es) 1998-07-24 2005-05-01 Teijin Limited Derivados del acido antranilico.
BR9913562A (pt) * 1998-09-11 2001-05-22 Ajinomoto Kk Derivados de benzeno, inibidor de ativação de ap-1 e nf-capa b, inibidor de produção de citoquina inflamatória, inibidor de produção de metaloprotease matricial ou inibidor de aparecimento de fator de adesão de célula inflamatório, e, agente antiinflamatório, anti-reumático, imunossupressor, inibidor de metástase cancerosa, remédio para arterioesclerose e agente antiviral
US20020065296A1 (en) 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
AU2871900A (en) 1999-02-04 2000-08-25 Millennium Pharmaceuticals, Inc. G-protein coupled heptahelical receptor binding compounds and methods of use thereof
CO5160290A1 (es) 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
US6159694A (en) * 1999-04-08 2000-12-12 Isis Pharmaceuticals Inc. Antisense modulation of stat3 expression
BR0012046A (pt) 1999-07-01 2002-05-14 Ajinomoto Kk Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
JP2001089412A (ja) * 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩
JP2001089450A (ja) * 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ピリジン誘導体含有医薬製剤
US20030220402A1 (en) 2000-02-15 2003-11-27 Naoki Tsuchiya Cancer remedy comprising anthranilic acid derivatives as active ingredients
OA12274A (en) * 2000-05-22 2006-05-09 Aventis Pharma Inc Arylmethylamine derivatives for use as tryptase inhibitors.
GB0015205D0 (en) 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
US6479510B2 (en) 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
EP1379127B1 (en) 2000-09-28 2013-04-17 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
AU2002223626A1 (en) 2000-10-20 2002-04-29 Novartis Ag Combinations of a thyromimetic compound and a statin
EP1211235A3 (en) 2000-11-30 2004-01-02 JFE Chemical Corporation Preparation process of 4,4'-Dicarboxydiphenyl ethers or derivatives thereof
JP2004269356A (ja) 2000-12-27 2004-09-30 Ajinomoto Co Inc 創傷部癒着防止剤
GB2374009A (en) 2001-02-12 2002-10-09 Novartis Ag Method of treating hair loss
SK15722003A3 (sk) 2001-06-20 2004-08-03 Pfizer Products Inc. Deriváty kyseliny sulfónovej a ich použitie
JP2005504059A (ja) 2001-08-24 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患を処置するための置換アリール７−アザ［２．２．１］ビシクロヘプタン
OA12670A (en) 2001-10-22 2006-06-20 Pfizer Prod Inc Piperazine derivatives with ccr1 receptor antagonist activity.
WO2003035602A1 (en) 2001-10-25 2003-05-01 Sankyo Company, Limited Lipid modulators
EP1480977A2 (en) 2002-02-15 2004-12-01 PHARMACIA & UPJOHN COMPANY Substituted aryl compounds for treatment of disease
FR2836917B1 (fr) 2002-03-11 2006-02-24 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
JP2004035475A (ja) 2002-07-03 2004-02-05 Ajinomoto Co Inc ＴＧＦβ作用抑制剤
RU2366655C2 (ru) 2003-03-14 2009-09-10 Оно Фармасьютикал Ко., Лтд. Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
EP1651595A2 (en) 2003-05-30 2006-05-03 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
DE602004027504D1 (de) 2003-07-24 2010-07-15 Leo Pharma As Aminobenzophenonverbindungen
ZA200700811B (en) 2004-08-06 2008-10-29 Otsuka Pharma Co Ltd Aromatic compound
CN101321529B (zh) 2005-12-05 2012-09-05 大塚制药株式会社 作为抗肿瘤剂的二芳基醚衍生物
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
TWI440638B (zh) 2007-10-30 2014-06-11 Otsuka Pharma Co Ltd 雜環化合物及其藥學組成物

Similar Documents

Publication Publication Date Title
JP2006298893A5 (https=)
RU2416608C2 (ru) Ароматическое соединение
RU2009116653A (ru) Ингибитор активации stat3/5
CA2537598C (en) Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
CN101321525B (zh) 作为l-cpt1抑制剂的杂芳基取代的哌啶衍生物
ES2390710T3 (es) Compuesto heterocíclico y composición farmacéutica del mismo
US7968570B2 (en) Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
CN103974950B (zh) 作为ccr(4)拮抗剂的取代的苯并咪唑类和苯并吡唑类
AU2010289353B2 (en) Compounds as tyrosine kinase modulators
RU2008127325A (ru) Лекарственное средство
JP2006500348A5 (https=)
CN101346372B (zh) 芳基-异*唑-4-基-*二唑衍生物
JP2010514788A5 (https=)
JP2005529161A (ja) ヒスタミンｈ３アンタゴニストとしての１−（４−ピペリジニル）ベンズイミダゾロン
JP2011503210A5 (https=)
JP2005533827A5 (https=)
CA2398388A1 (en) Novel piperidine compound and pharmaceutical thereof
SK17312001A3 (sk) Inhibítory metaloproteázy
CA2200468A1 (en) Muscarine antagonists
CN101595093A (zh) 有机化合物
PL187516B1 (pl) Nowe podstawione pochodne imidazolu, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki
BRPI0714407A2 (pt) composto triazolil fenil benzeno-sulfonamida, composiÇço compreendendo o mesmo, usos do mesmo, mÉtodos de modulaÇço de funÇço de ccr2 e ccr9
RU2005134006A (ru) Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера
JP2008513405A5 (https=)
CN101208311B (zh) 作为mGluR5拮抗剂的吡嗪-2-甲酰胺衍生物